I also understand there was an effort to clear the path for generic drugs to become available. Of course, generic drugs sell at a lesser cost than brand name drugs. A lot of the pharmaceutical people are opposed to that. It is also my understanding that this bill fails to carry through on the efforts to make it easy to bring generic drugs to market. Am I correct in that respect?
Discussing the availability of generic drugs during a debate on pharmaceutical legislation.
Share
More from John Sarbanes
This bill takes important steps to support the ongoing restoration of the Chesapeake Bay by reauthorizing NOAA's Chesapeake Bay Office and authorizing the agency's long-running Bay Watershed Education and Training, or B-WET Grant program.
It is important to be clear that EPA's proposed standards are reasonable, performance-based emissions standards and constitute neither a national electric vehicle mandate nor an internal combustion ban.
The goal was not to federalize elections across the country; the goal was to set some uniform standards.
Without the strong and continued investment the EPA has requested for the Chesapeake Bay Program in fiscal year 2024, the risk is we could jeopardize decades of work in collaboration towards the Bay's restoration.
Other voices in this conversation
